Skip to content

A clinical trial to assess diaphragm using ultrasound after giving interscalene block with different volumes of 0.5% Levo Bupivacaine

Effect of different volumes of 0.5 % Levo-Bupivacaine used for Interscalene Brachial Plexus Block on diaphragm as evaluated by ultrasound guidance - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054844
Enrollment
80
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: INTERSCALENE BLOCK: Ultrasound Guided Interscalene Brachial Plexus Block using 0.5% Injection Levo-Bupivacaine 15 ML Intervention2: INTERSCALENE BLOCK: Ultrasound Guided Interscalene Br

Sponsors

Indira Gandhi Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society of Anaesthesiologists (ASA) PHYSICAL STATUS CLASSS I & II 2. Patients undergoing surgery for fractures of Humerus

Exclusion criteria

Exclusion criteria: 1. Patient refusal for regional anaesthesia or unwillingness to participate in the study. 2. Patients allergic to local anaesthetics. 3. Local infection or scarring at the site of needle insertion. 4. Those who have coexisting respiratory failure. 5. Patients with upper limb deformities (congenital or acquired) and previous upper limb surgery i.e., nerve damage or paraesthesia in the affected limb 6. Any history of bleeding disorders. 7. Patients with morbid obesity i.e., BMI>=30 Kg/m2. 8. Any complication or adverse events during previous surgery under regional anaesthesia.

Design outcomes

Primary

MeasureTime frame
the incidence of diaphragmatic paralysis by evaluating excursion & velocity of diaphragm using USG should be different in the two groupsTimepoint: at 4 weeks, 8 weeks, 24 weeks, 48 weeks and at the end of trial (1 year)

Secondary

MeasureTime frame
the total duration of sensory & motor block in upper limb after Interscalene Brachial Plexus blockTimepoint: At 4 weeks, 8 weeks, 24 weeks 48 weeks & at the end of trial (1 year)

Countries

India

Contacts

Public ContactDr Atish Dipankar

Indira Gandhi Medical College

chaudhary.ushaarvind@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026